Lipid Profile Alterations during Fingolimod Treatment in Multiple Sclerosis Patients
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neuroimmune Pharmacology"
DOI: 10.1007/s11481-020-09937-4
Abstract: Fingolimod reduces inflammatory activity in multiple sclerosis (MS) by acting as a functional antagonist of sphingosine 1-phosphate (S1P) receptors. It has been suggested that S1P might also contribute to the antiatherogenic effect of high-density lipoprotein… read more here.
Keywords: lipid profile; fingolimod treatment; treatment; profile alterations ... See more keywords
MicroRNA Profile Alterations in Parathyroid Carcinoma: Latest Updates and Perspectives
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14040876
Abstract: Simple Summary Despite the considerable development of diagnostic tools, distinguishing between benign and malignant parathyroid tumors poses a significant diagnostic challenge. Epigenetic regulations, including noncoding microRNAs (miRNAs), have recently emerged as a new and promising… read more here.
Keywords: alterations parathyroid; expression; profile alterations; microrna profile ... See more keywords